Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production.

Charleston JS, Schnell FJ, Dworzak J, Donoghue C, Lewis S, Chen L, Young GD, Milici AJ, Voss J, DeAlwis U, Wentworth B, Rodino-Klapac LR, Sahenk Z, Frank D, Mendell JR.

Neurology. 2018 May 11. pii: 10.1212/WNL.0000000000005680. doi: 10.1212/WNL.0000000000005680. [Epub ahead of print]

PMID:
29752304
2.

Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Wilson K, Faelan C, Patterson-Kane JC, Rudmann DG, Moore SA, Frank D, Charleston J, Tinsley J, Young GD, Milici AJ.

Toxicol Pathol. 2017 Oct;45(7):961-976. doi: 10.1177/0192623317734823. Epub 2017 Oct 3.

PMID:
28974147
3.

Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons.

Li L, Nadanaciva S, Berger Z, Shen W, Paumier K, Schwartz J, Mou K, Loos P, Milici AJ, Dunlop J, Hirst WD.

PLoS One. 2013 Dec 31;8(12):e85815. doi: 10.1371/journal.pone.0085815. eCollection 2013.

4.

An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognition.

Shih HH, Tu C, Cao W, Klein A, Ramsey R, Fennell BJ, Lambert M, Ní Shúilleabháin D, Autin B, Kouranova E, Laxmanan S, Braithwaite S, Wu L, Ait-Zahra M, Milici AJ, Dumin JA, LaVallie ER, Arai M, Corcoran C, Paulsen JE, Gill D, Cunningham O, Bard J, Mosyak L, Finlay WJ.

J Biol Chem. 2012 Dec 28;287(53):44425-34. doi: 10.1074/jbc.M112.415935. Epub 2012 Nov 12.

5.

Age-dependent disruption in hippocampal θ oscillation in amyloid-β overproducing transgenic mice.

Scott L, Feng J, Kiss T, Needle E, Atchison K, Kawabe TT, Milici AJ, Hajós-Korcsok E, Riddell D, Hajós M.

Neurobiol Aging. 2012 Jul;33(7):1481.e13-23. doi: 10.1016/j.neurobiolaging.2011.12.010. Epub 2012 Jan 9.

PMID:
22227005
6.

Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease.

La Porte SL, Bollini SS, Lanz TA, Abdiche YN, Rusnak AS, Ho WH, Kobayashi D, Harrabi O, Pappas D, Mina EW, Milici AJ, Kawabe TT, Bales K, Lin JC, Pons J.

J Mol Biol. 2012 Aug 24;421(4-5):525-36. doi: 10.1016/j.jmb.2011.11.047. Epub 2011 Dec 13.

PMID:
22197375
7.

High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain.

Samaroo HD, Opsahl AC, Schreiber J, O'Neill SM, Marconi M, Qian J, Carvajal-Gonzalez S, Tate B, Milici AJ, Bales KR, Stephenson DT.

J Neurosci Methods. 2012 Feb 15;204(1):179-88. doi: 10.1016/j.jneumeth.2011.10.003. Epub 2011 Oct 12.

PMID:
22019329
8.

Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity.

Kiss T, Hoffmann WE, Scott L, Kawabe TT, Milici AJ, Nilsen EA, Hajós M.

Front Psychiatry. 2011 Apr 4;2:14. doi: 10.3389/fpsyt.2011.00014. eCollection 2011.

9.

PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases.

Runnels HA, Weber GL, Min J, Kudlacz EM, Zobel JF, Donovan CB, Thiede MA, Zhang J, Alpert RB, Salafia MA, Milici AJ, Burdette D, Bell RR, Beebe JS, Xu X.

Adv Ther. 2010 Mar;27(3):168-80. doi: 10.1007/s12325-010-0010-0. Epub 2010 Apr 26.

PMID:
20429046
10.

Defects in embryonic development of EGLN1/PHD2 knockdown transgenic mice are associated with induction of Igfbp in the placenta.

Ozolins TR, Fisher TS, Nadeau DM, Stock JL, Klein AS, Milici AJ, Morton D, Wilhelms MB, Brissette WH, Li B.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):372-6. doi: 10.1016/j.bbrc.2009.08.057. Epub 2009 Aug 14.

PMID:
19683511
11.

Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis.

Milici AJ, Kudlacz EM, Audoly L, Zwillich S, Changelian P.

Arthritis Res Ther. 2008;10(1):R14. doi: 10.1186/ar2365. Epub 2008 Jan 30.

12.

Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits.

Morehouse LA, Sugarman ED, Bourassa PA, Sand TM, Zimetti F, Gao F, Rothblat GH, Milici AJ.

J Lipid Res. 2007 Jun;48(6):1263-72. Epub 2007 Feb 26.

13.

Enterococcal virulence determinants may be involved in resistance to clinical therapy.

Marra A, Dib-Hajj F, Lamb L, Kaczmarek F, Shang W, Beckius G, Milici AJ, Medina I, Gootz TD.

Diagn Microbiol Infect Dis. 2007 May;58(1):59-65. Epub 2007 Feb 14.

PMID:
17300898
14.

Embryonic stem cells in predictive cardiotoxicity: laser capture microscopy enables assay development.

Chaudhary KW, Barrezueta NX, Bauchmann MB, Milici AJ, Beckius G, Stedman DB, Hambor JE, Blake WL, McNeish JD, Bahinski A, Cezar GG.

Toxicol Sci. 2006 Mar;90(1):149-58. Epub 2005 Dec 15.

PMID:
16357009
15.

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.

Changelian PS, Flanagan ME, Ball DJ, Kent CR, Magnuson KS, Martin WH, Rizzuti BJ, Sawyer PS, Perry BD, Brissette WH, McCurdy SP, Kudlacz EM, Conklyn MJ, Elliott EA, Koslov ER, Fisher MB, Strelevitz TJ, Yoon K, Whipple DA, Sun J, Munchhof MJ, Doty JL, Casavant JM, Blumenkopf TA, Hines M, Brown MF, Lillie BM, Subramanyam C, Shang-Poa C, Milici AJ, Beckius GE, Moyer JD, Su C, Woodworth TG, Gaweco AS, Beals CR, Littman BH, Fisher DA, Smith JF, Zagouras P, Magna HA, Saltarelli MJ, Johnson KS, Nelms LF, Des Etages SG, Hayes LS, Kawabata TT, Finco-Kent D, Baker DL, Larson M, Si MS, Paniagua R, Higgins J, Holm B, Reitz B, Zhou YJ, Morris RE, O'Shea JJ, Borie DC.

Science. 2003 Oct 31;302(5646):875-8.

16.

A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.

Chapman JG, Magee WP, Stukenbrok HA, Beckius GE, Milici AJ, Tracey WR.

Eur J Pharmacol. 2002 Dec 5;456(1-3):59-68.

PMID:
12450570
17.

Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide.

Geisler JG, Zawalich W, Zawalich K, Lakey JR, Stukenbrok H, Milici AJ, Soeller WC.

Diabetes. 2002 Jul;51(7):2158-69.

18.

Isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives as potent alpha(4)beta(1) integrin antagonists.

Duplantier AJ, Beckius GE, Chambers RJ, Chupak LS, Jenkinson TH, Klein AS, Kraus KG, Kudlacz EM, McKechney MW, Pettersson MP, Whitney CA, Milici AJ.

Bioorg Med Chem Lett. 2001 Oct 8;11(19):2593-6.

PMID:
11551757
19.

Cartilage damage after intraarticular exposure to collagenase 3.

Otterness IG, Bliven ML, Eskra JD, te Koppele JM, Stukenbrok HA, Milici AJ.

Osteoarthritis Cartilage. 2000 Sep;8(5):366-73.

20.

Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody.

Otterness IG, Downs JT, Lane C, Bliven ML, Stukenbrok H, Scampoli DN, Milici AJ, Mézes PS.

Matrix Biol. 1999 Aug;18(4):331-41.

PMID:
10517180
21.

Histology and tissue chemistry of tidemark separation in hamsters.

Otterness IG, Chang M, Burkhardt JE, Sweeney FJ, Milici AJ.

Vet Pathol. 1999 Mar;36(2):138-45.

PMID:
10098642
22.

Exercise protects against articular cartilage degeneration in the hamster.

Otterness IG, Eskra JD, Bliven ML, Shay AK, Pelletier JP, Milici AJ.

Arthritis Rheum. 1998 Nov;41(11):2068-76.

PMID:
9811063
23.

Early eosinophil infiltration into the optic nerve of mice with experimental allergic encephalomyelitis.

Milici AJ, Carroll LA, Stukenbrok HA, Shay AK, Gladue RP, Showell HJ.

Lab Invest. 1998 Oct;78(10):1239-44.

PMID:
9800949
24.

The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.

Showell HJ, Conklyn MJ, Alpert R, Hingorani GP, Wright KF, Smith MA, Stam E, Salter ED, Scampoli DN, Meltzer S, Reiter LA, Koch K, Piscopio AD, Cortina SR, Lopez-Anaya A, Pettipher ER, Milici AJ, Griffiths RJ.

J Pharmacol Exp Ther. 1998 Jun;285(3):946-54.

25.

Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice.

Griffiths RJ, Smith MA, Roach ML, Stock JL, Stam EJ, Milici AJ, Scampoli DN, Eskra JD, Byrum RS, Koller BH, McNeish JD.

J Exp Med. 1997 Mar 17;185(6):1123-9.

26.

Purification, visualization, and biophysical characterization of Kv1.3 tetramers.

Spencer RH, Sokolov Y, Li H, Takenaka B, Milici AJ, Aiyar J, Nguyen A, Park H, Jap BK, Hall JE, Gutman GA, Chandy KG.

J Biol Chem. 1997 Jan 24;272(4):2389-95.

27.

Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.

Gladue RP, Carroll LA, Milici AJ, Scampoli DN, Stukenbrok HA, Pettipher ER, Salter ED, Contillo L, Showell HJ.

J Exp Med. 1996 Apr 1;183(4):1893-8.

28.

Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).

Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, McNeish JD.

J Clin Invest. 1995 Apr;95(4):1512-8.

29.
30.

Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis.

Yocum SA, Lopresti-Morrow LL, Gabel CA, Milici AJ, Mitchell PG.

Arch Biochem Biophys. 1995 Feb 1;316(2):827-35.

PMID:
7864640
31.

Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.

Griffiths RJ, Pettipher ER, Koch K, Farrell CA, Breslow R, Conklyn MJ, Smith MA, Hackman BC, Wimberly DJ, Milici AJ, et al.

Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):517-21.

32.

Effects of exercise on synovium and cartilage from normal and inflamed knees.

Shay AK, Bliven ML, Scampoli DN, Otterness IG, Milici AJ.

Rheumatol Int. 1995;14(5):183-9.

PMID:
7724994
33.

Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.

Treadway JL, Hargrove DM, Nardone NA, McPherson RK, Russo JF, Milici AJ, Stukenbrok HA, Gibbs EM, Stevenson RW, Pessin JE.

J Biol Chem. 1994 Nov 25;269(47):29956-61.

34.

(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model.

Koch K, Melvin LS Jr, Reiter LA, Biggers MS, Showell HJ, Griffiths RJ, Pettipher ER, Cheng JB, Milici AJ, Breslow R, et al.

J Med Chem. 1994 Sep 30;37(20):3197-9. No abstract available.

PMID:
7932545
35.
36.

Changes in Mobility of the Golden Hamster with Induction of an IL-1-Induced Arthritis.

Otterness IG, Bliven ML, Milici AJ.

Mediators Inflamm. 1994;3(3):199-204.

37.

Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control.

Liu ML, Gibbs EM, McCoid SC, Milici AJ, Stukenbrok HA, McPherson RK, Treadway JL, Pessin JE.

Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11346-50.

38.

Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster.

Otterness IG, Milici AJ, Bliven ML.

Agents Actions. 1993 Nov;40(3-4):224-7.

PMID:
8023748
39.

Lectin and immunolabeling of microvascular endothelia.

Milici AJ, Porter GA.

J Electron Microsc Tech. 1991 Nov;19(3):305-15.

PMID:
1795184
40.
42.

Extracellular matrix specificity for the differentiation of capillary endothelial cells.

Carley WW, Milici AJ, Madri JA.

Exp Cell Res. 1988 Oct;178(2):426-34.

PMID:
3049122
43.

Transcytosis of albumin in capillary endothelium.

Milici AJ, Watrous NE, Stukenbrok H, Palade GE.

J Cell Biol. 1987 Dec;105(6 Pt 1):2603-12.

44.

The endothelial pocket. A new structure in fenestrated endothelia.

Milici AJ, Peters KR, Palade GE.

Cell Tissue Res. 1986;244(3):493-9.

PMID:
3719672
45.

The formation of fenestrations and channels by capillary endothelium in vitro.

Milici AJ, Furie MB, Carley WW.

Proc Natl Acad Sci U S A. 1985 Sep;82(18):6181-5.

46.
48.
49.

Supplemental Content

Loading ...
Support Center